Pioneers such as Merck, BMS, Genentech, Novartis, EMD Serono, and Amgen will unveil the very latest exciting industry intelligence leaving you bursting with insights, ideas and solutions.
Therefor I wouldn't agree with:
Unfortunately it is not a forum for introducing new data. JMO
However, I COULD agree that maybe Jeff H of PPHM has NOTHING new to report. Of course he is talking about PRE-CLINICAL and actually from that corner we never hear much unless it suddenly surfaces on such presentations.
The reserves i'd have to put on the above is that POSSIBLY (actually very likely) those 24+ collaborations Steve King has been talking about may, certainly in early stage, be MAINLY pre-clinical work.
Therefore it is uncertain because we do not know if such pre-clinical work would have resulted in some results if it would be PPHM, hence very probably Jeff H., or the partner of a given collaboration that would announce the results. And WHO would decide.
If PPHM wants the parties involved in the collaboration to remain UNKNOWN/UNDISCLOSED then we may hear results from PPHM or not at all because in all other cases the announcement with or by a partner of such collaboration will disclose its identity.